Despite operational challenges, Ceradyne's long-term diversification strategy remains intact. The near-term outlook is subdued due to solar market woes, delayed military contracts, and reduced body armour forecasts. The company is taking cost-cutting measures, but these headwinds are likely to persist in the next few quarters. Short-term pressure on the stock is anticipated. [-1]